| Execution period | FY 2026-2027 |
|---|
BSE filing, BSE: 543520. Summary written from the filing by ALFA Finder's alert engine.
Global Longlife Hospital and Research Ltd: key numbers
- Share price
- ₹12.08
- Market cap
- ₹12.68 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-1.72 Cr
- P/E (TTM)
- -7.4×Sector 34.1×
- Promoter holding
- 0.02%-22.86% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Longlife Hospital and Research Ltd
All →Global Longlife Hospital and Research Other Announcement
Global Longlife Hospital and Research Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Global Longlife Hospital and Research Annual General Meeting
Asahi Enterprise Limited (formerly Global Longlife Hospital) has scheduled an Extra Ordinary General Meeting for October 30, 2026, to ratify its name change compliance.
Global Longlife Hospital and Research Board Meeting Outcome
Asahi Enterprise Limited will hold an Extra-Ordinary General Meeting on October 30, 2026, to seek member approval for an issuance.
Global Longlife Hospital and Research Other Announcement
Global Longlife Hospital and Research Limited has changed its name to Asahi Enterprise Limited, following approval from the Registrar of Companies.
Global Longlife Hospital and Research Capital Structure Change
Abhishek Ashvinbhai Kamdar HUF acquired 5,35,000 shares of Global Longlife Hospital and Research Ltd via the open market. This constitutes a non-promoter stake acquisition.
Global Longlife Hospital and Research Other Announcement
Global Longlife Hospital and Research has amended its Memorandum of Association to expand its business scope into agricultural and textile trading activities.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.